French SME providing auditory preclinical efficacy and safety studies is looking for services agreement with life-sciences industries to accelerate the development of novel therapies
Based in France & US, the French SME is the one-stop partner for pharma, biotechs & medtechs developing novel therapies for people with hearing disorders. The company's mission is to give hope to the 466M people worldwide waiting for effective solutions. The company offers pharmacokinetics, efficacy, ototoxicity studies, & consulting, to assess drugs, devices, cell & gene therapies on hearing loss, tinnitus, & otitis under commercial or research agreements.